Navigation Links
Photos: Bayer Names New U.S. CEO
Date:7/31/2008

anagement in 1999 where he has served as Chairman of the Board Committee for Human Resources, Labor Director and the representative for the North American region, and as a member of the Board Committee for Technology and Environment.

Molnar was appointed President and Chief Executive Officer of Bayer Corporation and Senior Bayer Representative for the United States and Canada on July 1, 2002.

Since joining Bayer in 1978, Babe has held several management positions of increasing responsibility, including manager of the Brunsbuttel, Germany, facility; director and general manager of Hennecke Machinery, then a unit of Bayer's Polymers Division in Pennsylvania; vice president of corporate quality; and director of a national program to implement Bayer's enterprise resource planning system. He was named senior vice president of information services in 1999 before being named president and CEO of Bayer Corporate and Business Services LLC in 2003.

Babe serves on the Boards of Directors for Bayer MaterialScience LLC; Deerfield Urethane, Inc.; and Sheffield Plastics. In addition, he is the chair of the Bayer Political Action Committee (BAYPAC). For five years he served as the executive sponsor of the Bayer Diversity Advisory Council.

Babe also is serving his second term as chairman of the American Chemistry Council's Plastics Division Operating Committee. In Pittsburgh, he is a member of the Executive Committee and Board of Directors of the Pittsburgh Technology Council and a member of the Executive Committee and Board of Directors at Duquesne University serving as Vice Chair of Audit and Finance. Babe is also a member of West Virginia University's College of Engineering and Mineral Resources Advisory Committee.

A native of West Virginia, Babe holds a Bachelor of Science degree in mechanical engineering from West Virginia University. Babe and his wife, Carla, have four children and live in Mt. Lebanon, Pa.

Babe will remain in Pittsburg
'/>"/>

SOURCE Bayer
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Photos: MIKE AND IKE(R) Lemonade Blends(TM) and Alexs Lemonade Stand Foundation Join facebook(R)
2. Photos: For the First Time Researchers Show Reversal of an Aging Marker in the Human Retina Correlated with Visual Improvement Using a Nutraceutical Matrix (Longevinex(R))
3. Photos: The Multiple Sclerosis Association of America Produces a Web Video on the Importance of MRIs
4. Photos: Los Angeles Non Profit Teams With US Troops Stationed in Baghdad and Buaytha in Bringing a 5-Year-Old Blind Iraqi Girl, Whose Father Stands Beside US Combat Team Against Al Qaeda, to the US for a Groundbreaking Artificial Corneal Transplant Surger
5. Photos: New Kind of Health Care Reform Brings Five-Star Hospitality to Hospital Care
6. Photos: New Smoking Prevention Program Launched in Schools
7. Photos: Compact Barbell System With Flat, Streamlined Profile Travels Easily and Stores Conveniently
8. Photos: Niavin Corporation Offers Pain Sufferers a New Way to Address Pain
9. Photos: Drink Wine and Live Longer - 1907 Madiran and Plaimont Wines of Southwest France Sponsor the Launch of The Red Wine Diet
10. Photos: Americas Chronically Ill Children Have New Hope with Hot Gift
11. Photos: New Survey Shows Many Successful Quit Smoking Attempts Made Without Advance Planning
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Pausing Hormone Therapy Doesnt Cut Mammogram Recalls 47850 1Pausing Hormone Therapy Doesnt Cut Mammogram Recalls 47850 2U S Civil Rights Commission to Hold Public Briefing on Health Care Disparities Between Minorities and Non Minorities and Business Meeting 47848 1U S Civil Rights Commission to Hold Public Briefing on Health Care Disparities Between Minorities and Non Minorities and Business Meeting 47848 2U S Civil Rights Commission to Hold Public Briefing on Health Care Disparities Between Minorities and Non Minorities and Business Meeting 47848 3Anthem Blue Cross in California Provides More Members With Access to Comprehensive Transparency Tool 47846 1Anthem Blue Cross in California Provides More Members With Access to Comprehensive Transparency Tool 47846 2Anthem Blue Cross in California Provides More Members With Access to Comprehensive Transparency Tool 47846 3